BOLD NEWS why is Audentes Therapeutics, Inc. price falling or rising

BOLD NEWS reasons for why stock price of Audentes Therapeutics, Inc. is falling or rising

BOLD Audentes Therapeutics is falling or rising technical reasons

Technical analysis forecast for Audentes Therapeutics Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Audentes Therapeutics BOLD at this time. Stock is falling and might fall more.

It appears as if Audentes Therapeutics BOLD gave a large move recently.

Stock of Audentes Therapeutics (BOLD) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...

My analysis of Audentes Therapeutics is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Audentes Therapeutics stays below 1.7, but if it comes above 1.7, then a intra day buy could be more profitable.
If you take a sell trade below 1.7, then use 1.7 as stoploss and 1.5 as target. However if you take a buy trade in Audentes Therapeutics, then use 1.7 as stoploss and 1.84 as target.

BOLD Audentes Therapeutics is falling or rising NEWS fundamental reasons

Jim Walker nailed the 2008 stock market crash. Now he has 4 bold predictions for 2025 Aletheia Capital’s Chief Economist, Jim Walker, predicts a 10% decline in the US dollar, a painful but manageable economic slowdown, a long-term bullish trend in copper, and strong growth for Indian equities. He urges investors to double down on India, c - NEWS as on 2025-03-10 indiatimes.com

More announcements and NEWS

BOLD Audentes Therapeutics, Inc. current price & indicator signals